Neurophysidogic assessment of esophageal sensory processing in noncardiac chest pain

被引:45
作者
Hobson, AR
Furlong, PL
Sarkar, S
Matthews, PJM
Willert, RP
Worthen, SF
Unsworth, BJ
Aziz, Q
机构
[1] Univ Manchester, Div Med & Neurosci, Sect Gastrointestinal Sci, Hope Hosp, Salford M6 8HD, Lancs, England
[2] Aston Univ, Neurosci Res Inst, Wellcome Trust Lab Magnetoencephalog Studies, Birmingham B4 7ET, W Midlands, England
基金
英国医学研究理事会;
关键词
D O I
10.1053/j.gastro.2005.10.016
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Esophageal hypersensitivity is thought to be important in the generation and maintenance of symptoms in noncardiac chest pain (NCCP). In this study, we explored the neurophysiologic basis of esophageal hypersensitivity in a cohort of NCCP patients. Methods: We studied :12 healthy controls (9 women; mean age, 37.1 +/- 8.7 y) and 32 NCCP patients (23 women; mean age, 47.2 +/- 10 y). All had esophageal manometry, esophageal evoked potentials to electrical stimulation, and NCCP patients had 24-hour ambulatory pH testing. Results: The NCCP patients had reduced pain thresholds (PT) (72.1 +/- 19.4 vs 54.2 +/- 23.6, P =.02) and increased P1 latencies (P1 = 105.5 +/- 11.1 vs 118.1 +/- 23.4, P =.02). Subanalysis showed that the NCCP group could be divided into 3 distinct phenotypic classifications. Group I had reduced pain thresholds in conjunction with normal/reduced latency P1 latencies (n = 9). Group 2 had reduced pain thresholds in conjunction with increased (>2.5 SD) Pi latencies (n = 7), and group 3 had normal pain thresholds in conjunction with either normal (n = 10) or increased (>2.5 SD, n = 3) P1 latencies. Conclusions: Normal esophageal evoked potential latencies with reduced PT, as seen in group 1 patients, is indicative of enhanced afferent transmission and therefore increased esophageal afferent pathway sensitivity. Increased esophageal evoked potential latencies with reduced PT in group 2 patients implies normal afferent transmission to the cortex but heightened secondary cortical processing of this information, most likely owing to psychologic factors such as hypervigilance. This study shows that NCCP patients with esophageal hypersensitivity may be subclassified into distinct phenotypic subclasses based on sensory responsiveness and objective neurophysiologic profiles.
引用
收藏
页码:80 / 88
页数:9
相关论文
共 54 条
[1]   Treatment of spastic esophageal motility disorders [J].
Achem, SR .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (01) :107-+
[2]  
Achem SR, 1999, AM J GASTROENTEROL, V94, P5
[3]   The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain - a randomized, double-blind, placebo-controlled, crossover trial [J].
Bautista, J ;
Fullerton, H ;
Briseno, M ;
Cui, H ;
Fass, R .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (10) :1123-1130
[4]   Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron [J].
Berman, SM ;
Chang, L ;
Suyenobu, B ;
Derbyshire, SW ;
Stains, J ;
Fitzgerald, L ;
Mandelkern, M ;
Hamm, L ;
Vogt, B ;
Naliboff, BD ;
Mayer, EA .
GASTROENTEROLOGY, 2002, 123 (04) :969-977
[5]   Symptom hypersensitivity to acid infusion is associated with hypersensitivity of esophageal contractility [J].
Bhalla, V ;
Liu, JM ;
Puckett, JL ;
Mittal, RK .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2004, 287 (01) :G65-G71
[6]   Drugs targeting functional bowel disorders: lessons from drug trials [J].
Camilleri, M .
CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (06) :684-690
[7]   Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia [J].
Chang, L ;
Berman, S ;
Mayer, EA ;
Suyenobu, B ;
Derbyshire, S ;
Naliboff, B ;
Vogt, B ;
FitzGerald, L ;
Mandelkern, MA .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (06) :1354-1361
[8]   A multivariate T2 control chart for skewed populations using weighted standard deviations [J].
Chang, YS ;
Bai, DS .
QUALITY AND RELIABILITY ENGINEERING INTERNATIONAL, 2004, 20 (01) :31-46
[9]  
COHEN BR, 1970, MOD TREAT, V7, P1169
[10]  
DEMEESTER TR, 1980, J THORAC CARDIOV SUR, V79, P656